Hepatocellular Carcinoma News and Research

RSS
Remodeling the tumor microenvironment to unlock CAR-T cell potential

Remodeling the tumor microenvironment to unlock CAR-T cell potential

US cancer registries, constrained by Trump policies, to recognize only ‘male’ or ‘female’ patients

US cancer registries, constrained by Trump policies, to recognize only ‘male’ or ‘female’ patients

Neoantigens-loaded DC vaccines show strong potential to overcome tumor resistance

Neoantigens-loaded DC vaccines show strong potential to overcome tumor resistance

Do GLP-1 drugs cause cancer? New review says no, may even protect

Do GLP-1 drugs cause cancer? New review says no, may even protect

Liver cirrhosis found to be more common in low-income households

Liver cirrhosis found to be more common in low-income households

E2F2 protein identified as potential therapeutic target to prevent metabolic fatty liver disease progression

E2F2 protein identified as potential therapeutic target to prevent metabolic fatty liver disease progression

Groundbreaking 3D dynamic cell co-culture models simulate MASLD progression

Groundbreaking 3D dynamic cell co-culture models simulate MASLD progression

Study reports the world's first genetically engineered pig-to-human liver xenotransplantation

Study reports the world's first genetically engineered pig-to-human liver xenotransplantation

NCCN enhances widely used breast cancer guidelines with advanced digital features

NCCN enhances widely used breast cancer guidelines with advanced digital features

Study identifies key molecular and clinical biomarkers for MASLD

Study identifies key molecular and clinical biomarkers for MASLD

Targeting TGF-β signaling as a strategy to treat liver fibrosis

Targeting TGF-β signaling as a strategy to treat liver fibrosis

Coffee protects the liver by blocking inflammation and scarring, review finds

Coffee protects the liver by blocking inflammation and scarring, review finds

PANoptosis emerges as a promising strategy against liver cancer

PANoptosis emerges as a promising strategy against liver cancer

Novel biotechnical vector integrates viral and synthetic features for targeted cancer therapy

Novel biotechnical vector integrates viral and synthetic features for targeted cancer therapy

Study identifies C1orf122 as prognostic marker in liver cancer

Study identifies C1orf122 as prognostic marker in liver cancer

Novel vascularized cancer-on-a-chip model reflects the microenvironment of liver tumors

Novel vascularized cancer-on-a-chip model reflects the microenvironment of liver tumors

CHI3L1 emerges as a powerful biomarker for liver disease diagnosis and management

CHI3L1 emerges as a powerful biomarker for liver disease diagnosis and management

ATOX1 drives hepatocellular carcinoma progression through c-Myb and PI3K/AKT activation

ATOX1 drives hepatocellular carcinoma progression through c-Myb and PI3K/AKT activation

Fucosylation emerges as a key player in digestive inflammatory diseases and cancers

Fucosylation emerges as a key player in digestive inflammatory diseases and cancers

International commission calls for action against hepatocellular carcinoma

International commission calls for action against hepatocellular carcinoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.